Status: current, Defined. Date: 31-Aug 2018. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2612381000168110 | Lacteeze Extra Strength (tilactase 51 mg) chewable tablet, 10 tablets, blister pack (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2612391000168113 | Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | Is a | Lacteeze Extra Strength 51 mg chewable tablet, 10 | true | Inferred relationship | Some | ||
| Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | has TPUU | Lacteeze Extra Strength (tilactase 51 mg) chewable tablet (trade product unit of use) | true | Inferred relationship | Some | 1 | |
| Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | has container type | blister pack | true | Inferred relationship | Some | ||
| Lacteeze Extra Strength 51 mg chewable tablet, 10, blister pack | has TP | Lacteeze Extra Strength | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR